Monday, June 15, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 309 of 1,261

  1. US 11141393

    Treatment of vasculopathy with prostacyclin and mesenchymal stem cells

    United Therapeutics Corporation · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted

  2. US 11141400

    Method of treatment

    VANDA PHARMACEUTICALS INC. · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted

  3. US 11142504

    Substituted heterocycles as c-MYC targeting agents

    Northwestern University · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted

  4. US 11137409

    Identification of novel disease states using viscoelastic analysis in the presence of a thrombolytic agent

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  5. US 11135208

    1,4-dihydropyridine compositions, methods of making and use

    American Regent, Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  6. US 11135226

    Use of reboxetine to treat narcolepsy

    AXSOME THERAPEUTICS, INC. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  7. US 11136613

    Antibacterial polypeptide libraries and methods for screening the same

    The Board of Regents of the University of Texas System · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  8. US 11136557

    Adeno-associated virus variants and methods of use thereof

    The Regents of the University of California · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  9. US 11136582

    Ketohexokinase (KHK) iRNA compositions and methods of use thereof

    Alnylam Pharmaceuticals, Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  10. US 11136577

    Methods and compositions for inhibiting PMP22 expression

    Ionis Pharmaceuticals, Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  11. US 11136562

    Conditionally active heterodimeric polypeptides and methods of use thereof

    The Regents of the University of California · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  12. US 11135211

    Pimavanserin for treating impulse control disorder

    ACADIA Pharmaceuticals Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  13. US 11135172

    Rifabutin-based compositions and methods for treating Helicobacter pylori infection

    RedHill Biopharma Ltd. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  14. US 11135154

    Medroxyprogesterone acetate injectable compositions and methods of use

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  15. US 11136356

    Recombinant HIV-1 envelope proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  16. US 11136315

    CXCR2 antagonist

    Medshine Discovery Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  17. US 11136334

    Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione

    ACTUATE THERAPEUTICS INC. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  18. US 11135214

    Methods for enhancing the bio availability and exposure of a voltage-gated potassium channel opener

    Xenon Pharmaceuticals Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  19. US 11136321

    Tricyclic compounds

    Aligos Therapeutics, Inc. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  20. US 11136372

    ApoC-II mimetic peptides

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  21. US 11136350

    Method to produce an immunoglobulin preparation with improved yield

    Takeda Pharmaceutical Company Limited · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  22. US 11135309

    Poly(vinyl alcohol) nanocarriers

    The Regents of the University of California · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  23. US 11136297

    Compositions and methods for treating cancer

    The Regents of the University of California · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

  24. US 11135295

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.